Hematología y Hemoterapia

Resultados: 408
Tipo Título / Nombre Autor(es) Año
Lenalidomida + R-GDP (R2-GDP) en linfoma b difuso de células grandes refractario o en recaída. Resultados finales del ensayo R2-GDP-GOTEL Espejo García P, Martin García A, Palazón Carrión N, Nogales Fernández E, Carnicero González F, Rios Herranz E, et al 2020
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project Sargas C, Ayala R, Chillón MC, Larráyoz MJ, Carrillo-Cruz E..., Bergua J, et al 2020
Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry Martínez P, Palanques Pastor T, López Lorenzo JL, Cornago Navascués J, Rodríguez Macías G, Cano I, et al 2020
Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry Labrador J, Martínez Cuadrón D, Fuente A de la, Rodríguez Veiga R, Serrano J, Tormo M, et al 2020
Biomarker-Driven Phase Ib Clinical Trial of OPB-111077 in Acute Myeloid Leukemia Increases Overall Response Rates Martínez López J, Montesinos P, Martínez Sánchez P, Gorrochategui J, Rojas JL, Prino D, et al 2020
Measurable Residual Disease (MRD) in Elderly Acute Myeloid Leukemia (AML): Results from the Pethema-Flugaza Phase III Clinical Trial Simoes CP, Paiva B, Martínez Cuadron D, Bergua JM, Vives S, Algarra JL, et al 2020
Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia Valhondo I, Hassouneh F..., Bergua JM, Arcos MJ, Bañas H, Casas-Avilés I, et al 2020
Antithrombotic treatment in patients with factor VII deficiency: case reports Moriano B, Bermejo N, Rodríguez A, Espina M, Espina M, Ramos L, et al 2020
Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy Ribera JM, García O, Chapchap EC, Gil C, González-Campos J..., Bergua JM, et al 2020
Acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). study of 61 patients treated with intensive protocols Sitges M, Boluda B, Garrido A, Morgades M, Granada I ..., Bergua J, et al 2020